Andreas leads McKinsey’s capital-investment work for advanced industries in North America as well as our Center for Future Mobility on the West Coast. In his advisory work, Andreas serves a broad range of companies in the automotive sector, including car and truck manufacturers and their suppliers, as well as companies in the utilities and renewables space. He helps executives make strategic choices around product development while reducing material costs and optimizing the purchasing function. Andreas helps companies stay ahead of emerging trends, such as autonomous driving, connectivity, electric vehicles, and shared mobility.

Andreas holds a PhD in Operations Management and studied in Germany, France, the USA and Canada.

Armen Mkrtchyan is an Associate Partner in McKinsey’s Los Angeles Office and is a co-leader of McKinsey’s Center for Future Mobility on the West Coast.

At the Firm, Armen’s clients primarily include Automotive passenger and truck manufacturers and their suppliers. He also serves electronics and semiconductor players across the value chain both on operational and strategic topics.

Previously, Armen was the Founding Director of the Entrepreneurship and Product Innovation Center (EPIC) at the American University of Armenia and served as an Assistant Professor in the College of Engineering.

Armen has a PhD in Aeronautics and Astronautics from MIT and has worked on the development of various autonomous air and ground vehicles. He received his Bachelor’s degree in Electrical Engineering from the University of North Dakota and has multiple publications in the area of control systems, test and simulation, product development optimization.

Andreas leads McKinsey’s capital-investment work for advanced industries in North America as well as our Center for Future Mobility on the West Coast. In his advisory work, Andreas serves a broad range of companies in the automotive sector, including car and truck manufacturers and their suppliers, as well as companies in the utilities and renewables space. He helps executives make strategic choices around product development while reducing material costs and optimizing the purchasing function. Andreas helps companies stay ahead of emerging trends, such as autonomous driving, connectivity, electric vehicles, and shared mobility.

Andreas holds a PhD in Operations Management and studied in Germany, France, the USA and Canada.

Armen Mkrtchyan is an Associate Partner in McKinsey’s Los Angeles Office and is a co-leader of McKinsey’s Center for Future Mobility on the West Coast.

At the Firm, Armen’s clients primarily include Automotive passenger and truck manufacturers and their suppliers. He also serves electronics and semiconductor players across the value chain both on operational and strategic topics.

Previously, Armen was the Founding Director of the Entrepreneurship and Product Innovation Center (EPIC) at the American University of Armenia and served as an Assistant Professor in the College of Engineering.

Armen has a PhD in Aeronautics and Astronautics from MIT and has worked on the development of various autonomous air and ground vehicles. He received his Bachelor’s degree in Electrical Engineering from the University of North Dakota and has multiple publications in the area of control systems, test and simulation, product development optimization.

Take a tour of the Virtual SEMICON West rooms to visualize how easy attendees will navigate to the Expo Hall.

Preview how the virtual booths with look and interact during show days and the post event period to mid-September.

Review the lead generation opportunities that exist pre-show, at-show, and post-show.

Biography

Biography

Recent developments in both biological data acquisition and analysis provide new opportunities for data driven modeling of the health state of an organism. In this talk we explore geometric ideas and manifold learning methods for analyzing such data sets. In one example we examine the evolution of temperature patterns generated by telemetry data collected from healthy and infected Collaborative Cross mice challenged with Salmonella typhimurium. We visualize the interruption in circadian patterns and characterize the severity of infection within three days after exposure. This work was conducted in collaboration with David Threadgill and Helena Andrews-Polymenis of Texas A&M University.

Biography

A key to making digital care delivery easier is to augment biometric monitoring with predictive & prescriptive analytics. Optimized algorithms can efficiently tie together fragmented data sources, such as wearables & medical records. More importantly, they lay the foundation for intuitive workflows that guide clinical staff through effective triage & medical interventions.

Biography

The tissue engineered medical product (TEMP) industry has been held back historically by a lack of scalability, challenges with product consistency, and high final product costs. Over the last three decades, cutting edge science in the space has continued to advance while manufacturing tools and equipment specific to the needs of the field has lagged behind in development. To propel TEMP technologies into the commercial market, automation and sensor technologies need to be developed and implemented to make practical the scalable, consistent, cost-effective manufacturing of TEMPs. BioFabUSA is program of the Advanced Regenerative Manufacturing Institute (ARMI), an industry-led, member-driven, non-profit organization funded by the department of defense dedicated manufacturing of engineered tissues and tissue-related technologies. ARMI | BioFabUSA coordinates technology development projects that crosscut manufacturing areas in raw materials, automation, equipment, software, sensors and measurement tools, data management, preservation, processes, quality systems, and other pertinent elements of tissue engineered medical product manufacturing. With the combined effort of the ARMI membership, ARMI drives impactful advanced research and development activities that enable the development of a scalable, modular, automated and closed platform for the fabrication of TEMPs. This platform relies heavily on the integration of sensors and automation necessary to advance manufacturing technology development and demonstration, paving the way for compressed timelines for process design and development, as well as commercial, GMP-compliant manufacturing.

Biography

With an ongoing shift from managing disease towards the inclusion of maintaining health the world has seen the rise of increasingly sophisticated body monitoring and analytics. These tools are aiming to empower the individual to better navigate own health. They are also seeking to generate powerful insights towards the detection of subclinical symptoms or processes via existing and novel digital biomarkers. In that context a topic that is receiving increasing interest is the modulation of human physiology around an individual ‘baseline’ in everyday life and the dynamic around that. Today, there is more and more fully contextualised and truly long-term physiological data becoming available that allows deeper insights into the response of the human body to our behaviour, exposed environment or health events per se. This provides real life data in an unprecedented way. Insights emerging from that are fascinating, sometimes surprising and increasingly instructional.

This talk will provide an overview of where we have come from, what we are currently at and what’s unfolding in the convergence of different domains towards such more integrated and holistic health mapping and new opportunities in real word evidence driven clinical trials.

Biography

Biography

The United States has executed Aeromedical Evacuation (AE) for over 100 years. Originating with the first crude attempts at evacuating patients on biplanes in 1918. AE has evolved directly in line with the medical capabilities and advancements in aircraft. AE now provides the United States Air Force (USAF) with a global reach on various cargo and refueling aircraft. In the late 1980s, specialized Critical Care Air Transport Teams (CCATTs) developed to augment AE crews. CCATTs drastically changed medical care provided in our nation’s battlespaces. They allowed for more agile far forward casualty care and forged the En Route Care (ERC) systems. ERC is the backbone ensuring the survival of our wounded warriors and bringing them home to their families. The challenges abound when functioning in the ERC system to include the environment, the available resources, and personnel limitations. Exploring and targeting these challenge areas will continue to allow ERC to keep in step with our ever‐changing mission requirements and progress the impressive legacy of bringing heroes home.

Biography

As compared to conventional, rigid, bulky physiological monitoring tools, emerging onskin wearable biomedical devices are ultrathin, lightweight, and small footprint and can find wide applications in point of care diagnostics because of their easy deployment outside the hospital settings. At present, on-skin wearables are usually fabricated by patterning conventional inorganic materials, novel organic materials, or emerging nanomaterials on continuous (i.e., non-porous) flexible supporting substrates. Consequently, the state-of-the-art on-skin wearables often suffer from expensive precursor materials, costly fabrication facilities, complex fabrication processes, and limited functionalities and disposability. By using widely accessible pencils and papers as the fabrication tools, we have developed a rich variety of cost-effective and disposable on-skin bioelectronic devices, ranging from biophysical sensors and sweat biochemical sensors to thermal stimulators, humidity energy harvesters, and transdermal drug delivery systems. The enabled devices can find wide applications in point of care diagnostics, particularly in low-resource environments owing to their low-cost resources, handy operation, time-saving fabrication, and abundant potential designs. Besides, by using judiciously engineered porous elastomer as supporting substrates, on-skin wearable devices with high breathability and self-cooling capability can be achieved.

Biography

An overview of the DHA virtual health program including driving factors, high level requirements, and pathway forward. The presentation will also provide an update on the DoD virtual health COVID-19 response and the value provided to patient care through virtual health.

Biography

Wireless wearable devices can continuously assess and communicate the condition of patients and are crucial components of the are crucial components of the move towards digital, mobile health monitoring. We envision that widespread adoption of disposable wireless devices has the potential to radically transform care-giving in clinical settings. Implementation of continuous patient monitoring could make practices such as spot-checking patient vital signs during hospitalization obsolete. Furthermore, earlier patient discharge may become possible through earlier and safer patient mobilization enabled by wireless monitoring. In this talk, we will discuss flexible hybrid electronic manufacturing opportunities and challenges to create low cost, high performance wireless sensor systems for patient monitoring. These single use devices will support 3-Lead ECG, reflective SpO2, respiration rate and core body temperature sensing on a continuous basis for 72 hours.

Biography

Biography

There is an entire field of research dedicated to the chemical analysis of exhaled breath, and the enticing promise of non-invasive medical diagnostics and monitoring. Interestingly, we know that sampling plays a key role in the metabolite content in this complex sample, and biomarker detection and identification in breath may rest on appropriate sampling and analysis protocols. There is also some evidence on how breath chemicals change over time and in response to illness, diet, overall health and exposures. There are also studies that show exogenous drugs measured in breath as well. This talk with highlight our own basic research in this area.

Jennifer's Biography | Sean's Biography

Historically, biomarker discovery efforts have focused on developing sensing strategies for disease diagnosis and prognosis. More recently, the Department of Defense has made a significant investment in wearable sensor and data analytics methods to predict physiologic and cognitive detriment with the goal of improving personnel readiness and augmenting human performance. During this presentation, a broad overview of not only biomarker discovery approaches within Air Force Research Laboratories will be provided, but also future trends and technology gaps limiting fielding of wearable devices, outlining the underpinning for potential external collaborations.

Biography

There are several compounds that interfere with accurate sensing of metabolic analytes in the subcutaneous space, including drugs and endogenous compounds. In addition, when a glucose sensor is exposed to a delivered insulin formulation, there are additional interference issues. Methods of overcoming these threats to accurate sensing will be discussed.

Abstract & Biography